Dosage aspects of danazol therapy in the treatment of endometriosis
Non-randomised trial
OA: green
CC0
⤵ 7 in-corpus citations
AI-generated summary
Danazol effectively treats endometriosis, but optimal dosage requires individual trial and error starting from recommended initial doses due to variable patient response and requirements.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Danazol is effective in the treatment of endometriosis. Individual patient response is very variable as is dosage requirement. The appropriate dose for maintenance therapy for any particular patient is best determined by a trial and error method, starting with a recommended initial dosage. Side effects are slight.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (7)
- Danazol 2022
- Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository 1995
- Treatment with danazol and plasma glucagon concentration 1985
- Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up 1985
- Interim report of a study of danazol for the treatment of endometriosis 1985
- Danazol in the treatment of endometriosis 1980
- Endometriosis—continuing conundrum 1980
SciLite annotations
chemicals 2
danazol
danazol
Source provenance
- europepmc
- last seen: 2026-10-17T06:09:56.316927+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:46:40.609885+00:00
- scilite
- last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0
· commercial use OK